| Source: |
| Type: |
| NLRP3 (NOD-like receptor pyrin domain-containing protein 3) is a protein that plays a crucial role in the regulation of inflammation and immune responses. NLRP3 typically has high expression in cancers, with poor prognosis. For alzheimer's disease: -NLRP3 is upregulated in Alzheimer's disease (AD) -NLRP3 is activated in microglia in response to amyloid-β (Aβ) and tau aggregates. -Promotes tau hyperphosphorylation and spread via inflammation-driven pathways. |
| 3330- | SIL, | Mechanistic Insights into the Pharmacological Significance of Silymarin |
| - | Review, | Var, | NA |
| 3324- | SIL, | Silymarin prevents NLRP3 inflammasome activation and protects against intracerebral hemorrhage |
| 2354- | SK, | PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation |
| - | in-vivo, | Sepsis, | NA |
| 2119- | TQ, | Dual properties of Nigella Sativa: anti-oxidant and pro-oxidant |
| - | Review, | Var, | NA |
| 3420- | TQ, | Thymoquinone alleviates the accumulation of ROS and pyroptosis and promotes perforator skin flap survival through SIRT1/NF-κB pathway |
| - | in-vitro, | Nor, | HUVECs | - | in-vitro, | NA, | NA |
| 3419- | TQ, | Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients |
| - | in-vitro, | BC, | NA |
| 3418- | TQ, | Thymoquinone suppresses metastasis of melanoma cells by inhibition of NLRP3 inflammasome |
| - | in-vitro, | Melanoma, | A375 | - | in-vivo, | NA, | NA |
| 5022- | UA, | Ursolic Acid’s Alluring Journey: One Triterpenoid vs. Cancer Hallmarks |
| - | Review, | Var, | NA |
| 4869- | Uro, | Urolithin A in Central Nervous System Disorders: Therapeutic Applications and Challenges |
| - | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
| 4876- | Uro, | Urolithin A in Health and Diseases: Prospects for Parkinson’s Disease Management |
| - | Review, | Park, | NA | - | Review, | AD, | NA |
| 4880- | Uro, | Urolithins: A Prospective Alternative against Brain Aging |
| - | Review, | AD, | NA |
| 3125- | VitC, | Vitamin C inhibits NLRP3 inflammasome activation and delays the development of age-related hearing loss in male C57BL/6 mice |
| - | in-vivo, | Nor, | NA |
| 3126- | VitC, | Safety of High-Dose Vitamin C in Non-Intensive Care Hospitalized Patients with COVID-19: An Open-Label Clinical Study |
| - | Study, | NA, | NA |
| 3127- | VitC, | NLRP3_inflammasome_by_scavenging_mitochondrial_ROS">Vitamin C inhibits the activation of the NLRP3 inflammasome by scavenging mitochondrial ROS |
| - | in-vitro, | Nor, | NA | - | in-vivo, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:908 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid